MET Compass is aimed at lung cancer treating physicians navigating the patient journey of those living with advanced lung cancer with METEX14 skipping mutation. Presented and prepared by Dr. Nicolas Marcoux, this program uses a patient case, to explore METEX14 treatment landscape and effective adverse event management strategies.

 

Currently available programs:

CA-NONGM-00006